Record James Cameron’s blockbuster nears seven million admissions in two weeks
Globally, the film has already exceeded one billion in revenue. — EyePress News//SIPA
“Not happy? Record.” James Cameron will be able to take over the punchline of Kylian Mbappé during his next interview, while his film Avatar : the way of the water became on the wire the most seen film in the cinema in France in 2022. Released in mid-December, the blockbuster has since attracted more than 6.87 million viewers in theaters, dethroning Top Gun : Maverick, annouced; its distributor Disney on Friday.
“With 559,147 entries for Thursday, #AvatarLaVoiedeLeau reached 6,870,704 entries last night. Best Result of a Motion Picture in 2022” on Twitter Frédéric Monnereau, in charge of distribution at Disney. At the world level, France offers the film by James Cameron, who has already exceeded $1 billion in revenue, its third largest estimated income, behind the United States and China.
Sequels have a future
A record-breaking filmmaker, James Cameron is already at it. the author, after Titanic, of the most profitable film at; today, the first installment of Avatar, approaching $2.9 billion in revenue. In France, it’s a lightning triumph, fueled by by the school holidays during which more than 500,000 spectators a day embarked; for the Pandora star since the release of this new Avatar on December 14.
A frantic pace; which allows him to dethrone on New Year’s Eve, Tom Cruise’s fighter jet and the 6.76 million admissions achieved with his Top Gun comeback since May. If no one ventures to bet on his final score, the new Avatarshould continue to achieve several million admissions at the start of 2023. The first part, 13 years ago, had attracted a total of 14.7 million viewers.
Enough to put a smile on the face of theater operators, after a year 2022 where a part of the public was again lacking. Official attendance figures for French cinemas will not be released until Monday, but attendance should still be down by around a quarter compared to last week. before-Covid.